Entity Details

Primary name DPOE1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ07864
EntryNameDPOE1_HUMAN
FullNameDNA polymerase epsilon catalytic subunit A
TaxID9606
Evidenceevidence at protein level
Length2286
SequenceStatuscomplete
DateCreated1994-10-01
DateModified2021-06-02

Ontological Relatives

GenesPOLE

GO terms

Show/Hide Table
GOName
GO:0000082 G1/S transition of mitotic cell cycle
GO:0000166 nucleotide binding
GO:0000278 mitotic cell cycle
GO:0000731 DNA synthesis involved in DNA repair
GO:0003677 DNA binding
GO:0003682 chromatin binding
GO:0003887 DNA-directed DNA polymerase activity
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005886 plasma membrane
GO:0006260 DNA replication
GO:0006270 DNA replication initiation
GO:0006272 leading strand elongation
GO:0006287 base-excision repair, gap-filling
GO:0006297 nucleotide-excision repair, DNA gap filling
GO:0008270 zinc ion binding
GO:0008310 single-stranded DNA 3'-5' exodeoxyribonuclease activity
GO:0008622 epsilon DNA polymerase complex
GO:0045004 DNA replication proofreading
GO:0048568 embryonic organ development
GO:0051539 4 iron, 4 sulfur cluster binding

Subcellular Location

Show/Hide Table
Subcellular Location
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR006133 DNA-directed DNA polymerase, family B, exonuclease domainDomainDomain
IPR006134 DNA-directed DNA polymerase, family B, multifunctional domainDomainDomain
IPR006172 DNA-directed DNA polymerase, family BFamilyFamily
IPR012337 Ribonuclease H-like superfamilyFamilyHomologous superfamily
IPR013697 DNA polymerase epsilon, catalytic subunit A, C-terminalDomainDomain
IPR029703 DNA polymerase epsilon catalytic subunitFamilyFamily
IPR036397 Ribonuclease H superfamilyFamilyHomologous superfamily
IPR042087 DNA polymerase family B, thumb domainFamilyHomologous superfamily
IPR043502 DNA/RNA polymerase superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618336 OMIMIntrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI)An autosomal recessive disorder characterized by intrauterine growth retardation, postnatal growth failure, metaphyseal dysplasia, adrenal hypoplasia congenita, growth hormone deficiency, genital anomalies, and immunodeficiency resulting in increased infections. The disease is caused by variants affecting the gene represented in this entry.
615139 OMIMFacial dysmorphism, immunodeficiency, livedo, and short stature (FILS)A syndrome characterized by mild facial dysmorphism, mainly malar hypoplasia, livedo on the skin since birth, and immunodeficiency resulting in recurrent infections. Growth impairment is observed during early childhood and results in variable short stature in adulthood. The disease is caused by variants affecting the gene represented in this entry.
615083 OMIMColorectal cancer 12 (CRCS12)A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. CRCS12 is characterized by a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. Onset is usually before age 40 years. The histologic features of the tumors are unremarkable. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00242 CladribineDrugbanksmall molecule